Prague Med Rep. 2004;105(1):64-8.

Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis--preliminary single center experience.

Rihová Z, Jancová E, Merta M, Zabka J, Rysavá R, Bartůnková J, Kolárova I, Tesar V.

Source

First Department of Medicine, U Nemocnice 2, 128 08 Praha 2, Czech Republic. zrihova@centrum.cz

Abstract

The aim of the multicentric randomized trial CYCLOPS is to optimize the treatment of induction of remission in patients with generalized, but not immediately life-threatening ANCA (antineutrophil cytoplasmic antibodies) -associated vasculitis. This will be achieved by reducing the dose of cyclophosphamide by administering it as intermittent pulses. The lower cumulative dose will be very probably accompanied with lower toxicity, whereas the effectivity should be comparable. We have enrolled 28 patients to the study. At present, 18 of them are suitable for evaluation. Our preliminary results show that pulse intermittent administration of cyclophosphamide is safer from the point of morbidity and mortality due to infectious complications. In our hands, this treatment modality does not seem to be less effective than the conventional daily oral cyclophosphamide. However, unambiguous results and treatment recommendations will not be available until the final evaluation of all patients enrolled in the trial.

PMID:: 15354947; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Supplemental Content

Save items

Related citations in PubMed

Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial. [Ann Intern Med. 2009]
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.
de Groot K, Harper L, Jayne DR, Flores Suarez LF, Gregorini G, Gross WL, Luqmani R, Pusey CD, Rasmussen N, Sinico RA, et al. Ann Intern Med. 2009 May 19; 150(10):670-80.
[Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)]. [Z Rheumatol. 2009]
[Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)].
Kötter I. Z Rheumatol. 2009 Sep; 68(7):575-7.
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. [Arthritis Rheum. 1998]
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.
Haubitz M, Schellong S, Göbel U, Schurek HJ, Schaumann D, Koch KM, Brunkhorst R. Arthritis Rheum. 1998 Oct; 41(10):1835-44.
Review [Cyclophosphamide versus bolus in Wegener's granulomatosis and other ANCA-related vasculitides: advantages and disadvantages]. [Z Rheumatol. 2009]
Review [Cyclophosphamide versus bolus in Wegener's granulomatosis and other ANCA-related vasculitides: advantages and disadvantages].
Reinhold-Keller E, Warnatz K. Z Rheumatol. 2009 Jun; 68(4):345-8.
Review Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis. [Nephron Clin Pract. 2004]
Review Prolonged treatment with low-dose intravenous pulse cyclophosphamide may reduce rate of relapse in ANCA-associated vasculitis.
Dhaygude A, Griffith M, Cairns T, McLean A, Palmer A, Taube D. Nephron Clin Pract. 2004; 97(4):c154-9.

See reviews... See all...

Cited by 1 PubMed Central article

Review Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist. [Crit Care. 2007]
Review Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist.
Papiris SA, Manali ED, Kalomenidis I, Kapotsis GE, Karakatsani A, Roussos C. Crit Care. 2007; 11(3):213.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-asso...
Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis--preliminary single center experience.
Prague Med Rep. 2004 ;105(1):64-8.

PubMed
[Is sufentanil suitable for long-term sedation of a critically ill patient?].
[Is sufentanil suitable for long-term sedation of a critically ill patient?].
Anaesthesist. 1992 ;41(5):271-5.

PubMed
[Use of the "c-clamp" in the emergency treatment of unstable pelvic fractures].
[Use of the "c-clamp" in the emergency treatment of unstable pelvic fractures].
Zentralbl Chir. 2004 Aug ;129(4):245-51.

PubMed
Do the results of randomized clinical trials of cardiovascular drugs influence m...
Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators.
N Engl J Med. 1992 Jul 23 ;327(4):241-7.

PubMed
Aortic valve replacement with the minimal extracorporeal circulation (Jostra MEC...
Aortic valve replacement with the minimal extracorporeal circulation (Jostra MECC System) versus standard cardiopulmonary bypass: a randomized prospective trial.
J Thorac Cardiovasc Surg. 2004 Sep ;128(3):436-41.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis--preliminary single center experience.

Source

Abstract

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Medical

Molecular Biology Databases

Libraries

Supplemental Content

Save items

Related citations in PubMed

Cited by 1 PubMed Central article

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information